13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q3 2025 · Filed November 13, 2025 · Accession 0000902664-25-004910
Total Value
$68.0M
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 5,664,548 | $41.5M | 60.97% |
| 2 | INVIVYD INC | IVVD | 9,248,250 | $10.2M | 14.96% |
| 3 | TG THERAPEUTICS INC | TGTX | 161,600 | $5.8M | 8.58% |
| 4 | FRACTYL HEALTH INC | GUTS | 1,856,117 | $3.0M | 4.34% |
| 5 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $2.3M | 3.42% |
| 6 | PROQR THRAPEUTICS N V | N71542109 | 1,019,498 | $2.2M | 3.19% |
| 7 | ROCKET PHARMACEUTICALS INC | RCKTW | 385,680 | $1.3M | 1.85% |
| 8 | SILENCE THERAPEUTICS PLC | SLNCF | 185,100 | $960,669 | 1.41% |
| 9 | CURIS INC | CRIS | 521,059 | $864,958 | 1.27% |